KORU MEDICAL SYSTEMS INC

CEO Adam Kalbermattens’ $0 PSU deal and board buying signal confidence in Koru Medical’s 2030 growth targets, hinting at a potential breakout for this volatile medical‑device stock.

Insider buying at KORU Medical Systems shows exec confidence amid volatility: modest CT‑O purchase, long‑term growth bet, and potential regulatory upside.

CEO Tharby Linda M’s recent purchase of KORU Medical shares shows confidence in the company’s growth, hinting at potential upside amid volatility.

CEO Tharby Linda M continues buying KORU shares, signaling confidence in the firm’s growth in subcutaneous infusion devices.

Insider trades reveal KORU Medical’s executives buying shares but selling to cover taxes, signaling confidence without affecting market supply.